Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay

被引:66
作者
Calaf, Raymond [1 ]
Cerini, Claire [2 ]
Genovesio, Cecile [1 ]
Verhaeghe, Pierre [7 ,8 ,9 ]
Jourde-Chiche, Noemie [2 ,3 ]
Berge-Lefranc, David [4 ]
Gondouin, Bertrand [2 ,3 ]
Dou, Laetitia [2 ]
Morange, Sophie [5 ]
Argiles, Angel [6 ]
Rathelot, Pascal [7 ,8 ,9 ]
Dignat-George, Francoise [2 ]
Brunet, Philippe [2 ,3 ]
Charpiot, Philippe [1 ,2 ]
机构
[1] Univ Mediterranee, Lab Biochim Mol Fondamentale & Clin, UFR Pharm, F-13385 Marseille 5, France
[2] Univ Mediterranee, UMR INSERM 608, UFR Pharm, F-13385 Marseille 5, France
[3] Hop Conception, AP HP, Ctr Nephrol & Transplantat Renale, F-13005 Marseille, France
[4] Univ Mediterranee, Unite Chim Phys Prevent Risques & Nuisances Techn, UFR Pharm, F-13385 Marseille 5, France
[5] Hop Conception, Ctr Invest Clin, INSERM, F-13005 Marseille, France
[6] Ecole Natl Super Chim, RD Nephrol & Grp Rein & HTA, EA3127, Inst Univ Rech Clin IURC UM1, F-34090 Montpellier, France
[7] Univ Aix Marseille 1, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[8] Univ Aix Marseille 2, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
[9] Univ Aix Marseille 3, Lab Chim Provence, UMR CNRS Equipe Pharmacochim Radicalaire 6264, UFR Pharm,Univ Mediterranee, F-13385 Marseille 5, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 23期
关键词
Chronic kidney disease; Uremic solutes; Ion-pairing HPLC; P-CRESYL SULFATE; INDOXYL SULFATE; TOXINS; SERUM; INDUCTION; MORTALITY; CRESYLSULPHATE; PLASMA; PHENOL;
D O I
10.1016/j.jchromb.2011.06.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
During chronic kidney disease (CKD), solutes called uremic solutes, accumulate in blood and tissues of patients. We developed an HPLC method for the simultaneous determination of several uremic solutes of clinical interest in biological fluids: phenol (Pol), indole-3-acetic acid (3-IAA), p-cresol (p-C), indoxyl sulfate (3-INDS) and p-cresol sulfate (p-CS). These solutes were separated by ion-pairing HPLC using an isocratic flow and quantified with a fluorescence detection. The mean serum concentrations of 3-IAA, 3-INDS and p-CS were 2.12, 1.03 and 13.03 mu M respectively in healthy subjects, 3.21, 17.45 and 73.47 mu M in non hemodialyzed stage 3-5 CKD patients and 5.9, 81.04 and 120.54 mu M in hemodialyzed patients (stage 5D). We found no Pol and no p-C in any population. The limits of quantification for 3-IAA, 3-INDS, and p-CS were 0.83, 0.72, and 3.2 mu M respectively. The within-day CVs were between 1.23 and 3.12% for 3-IAA, 0.98 and 2% for 3-INDS, and 1.25 and 3.01% for p-CS. The between-day CVs were between 1.78 and 5.48% for 3-IAA, 1.45 and 4.54% for 3-INDS, and 1.19 and 6.36% for p-CS. This HPLC method permits the simultaneous and quick quantification of several uremic solutes for daily analysis of large numbers of samples. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:2281 / 2286
页数:6
相关论文
共 50 条
  • [21] Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease
    Black, Ana Paula
    Cardozo, Ludmila F. M. F.
    Mafra, Denise
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (05) : 436 - 440
  • [22] Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
    Gryp, Tessa
    Huys, Geert R. B.
    Joossens, Marie
    Van Biesen, Wim
    Glorieux, Griet
    Vaneechoutte, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [23] Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis
    Iguchi, Akira
    Yamamoto, Suguru
    Oda, Akira
    Tanaka, Kenichi
    Kazama, Junichiro James
    Saeki, Takako
    Yamazaki, Hajime
    Ishioka, Ken
    Suzutani, Tatsuo
    Narita, Ichiei
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (08) : 725 - 733
  • [24] Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
    Kaminski, Tomasz W.
    Pawlak, Krystyna
    Karbowska, Malgorzata
    Mysliwiec, Michal
    Pawlak, Dariusz
    BMC NEPHROLOGY, 2017, 18
  • [25] Clinical profile of Uremic polyneuropathy in Chronic Kidney Disease patients
    Aradhey, Parag
    Bakre, Anand
    Kumar, Sunil
    Acharya, Sourya
    MEDICAL SCIENCE, 2020, 24 (102) : 945 - 951
  • [26] Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease
    Poesen, Ruben
    Viaene, Liesbeth
    Verbeke, Kristin
    Augustijns, Patrick
    Bammens, Bert
    Claes, Kathleen
    Kuypers, Dirk
    Evenepoel, Pieter
    Meijers, Bjorn
    BMC NEPHROLOGY, 2014, 15
  • [27] Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
    Lim, Yong Jin
    Sidor, Nicole A.
    Tonial, Nicholas C.
    Che, Adrian
    Urquhart, Bradley L.
    TOXINS, 2021, 13 (02)
  • [28] Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease
    Wulczyn, Kendra E.
    Zhao, Sophia H.
    Rhee, Eugene P.
    Kalim, Sahir
    Shafi, Tariq
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (04): : 496 - 506
  • [29] Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
    Hamza, Eya
    Metzinger, Laurent
    Metzinger-Le Meuth, Valerie
    CELLS, 2020, 9 (09) : 1 - 18
  • [30] The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease
    Lu, Ping-Hsun
    Yu, Min-Chien
    Wei, Meng-Jiun
    Kuo, Ko-Lin
    TOXINS, 2021, 13 (08)